Dr. Omar Al Hamdan

Dr. Omar Al Hamdan is a consultant neurologist at Mediclinic City Hospital in Dubai Healthcare City — a purpose-built medical free zone that houses some of the UAE's most advanced specialist practices. Over two decades, Dr. Al Hamdan has developed particular expertise in the acute management of stroke and the long-term care of patients with multiple sclerosis and epilepsy, conditions that require sustained specialist follow-up and careful medication titration.

His approach to stroke care is grounded in the principle that time is brain: he works closely with the emergency department and neuroradiologists to ensure rapid assessment and treatment of acute ischaemic and haemorrhagic stroke, including intravenous thrombolysis and coordination for thrombectomy where indicated. He leads a post-stroke rehabilitation clinic that integrates physiotherapy, speech therapy, and occupational therapy under neurological oversight.

In the field of multiple sclerosis, Dr. Al Hamdan has built one of the UAE's most active MS clinics, supporting a large population of both Emirati and expatriate patients. He is experienced in the use of all classes of disease-modifying therapies for relapsing-remitting and progressive MS and participates in monitoring programs for high-efficacy immunotherapies.

Dr. Al Hamdan is also recognized for his work in epilepsy, managing patients with drug-resistant seizures and coordinating presurgical epilepsy evaluations with neurosurgical colleagues. He communicates fluently in Arabic and English, ensuring that patients of all backgrounds can fully engage in their neurological care.

Dr. Al Hamdan obtained his MBBS at the University of Jordan Faculty of Medicine, followed by internal medicine residency training in the UAE. He completed his MRCP (Neurology) in the United Kingdom and undertook a Neurology Fellowship at King's College Hospital in London, with subspecialty training in stroke neurology. He subsequently completed an MS Fellowship at the Multiple Sclerosis Society of Canada's designated center at the University of Toronto. He holds the FRCP designation from the Royal College of Physicians and maintains active membership in the American Academy of Neurology and the European Academy of Neurology.

Dr. Al Hamdan's clinical focus spans three primary areas: acute stroke, demyelinating disease, and epilepsy. In stroke, he performs and interprets brain MRI including DWI and perfusion imaging, administers IV alteplase for eligible patients, and coordinates mechanical thrombectomy with interventional neuroradiology. In MS, he prescribes and monitors disease-modifying therapies including interferon-betas, glatiramer acetate, natalizumab, ocrelizumab, and cladribine. For epilepsy, he performs and interprets EEG, manages polytherapy, and coordinates video-EEG for complex cases. He also performs botulinum toxin injections for chronic migraine, spasticity, and hemifacial spasm.

Dr. Al Hamdan has contributed to regional neurology research examining the prevalence of MS in Gulf Arab populations and stroke outcomes in the UAE's ethnically diverse patient population. He has co-authored articles in the Journal of the Neurological Sciences and presented at the Emirates Neurology Society annual conference. He collaborates with the Mediclinic City Hospital research committee on quality improvement initiatives in stroke care pathway performance metrics.

Mediclinic City Hospital's location within Dubai Healthcare City and its JCI accreditation make it a natural destination for patients from across the Arab world, South Asia, and Africa seeking neurological specialist care. Dr. Al Hamdan consults in Arabic and English and regularly reviews overseas imaging and diagnostic reports for patients seeking second opinions on stroke prognosis, MS diagnosis, or epilepsy management. Video consultations are available for initial assessment and ongoing monitoring, minimizing travel for patients managing chronic neurological conditions.

Dr. Al Hamdan has been recognized by the Emirates Neurology Society for his contribution to stroke care quality improvement in the UAE. He has received clinical excellence commendations from Mediclinic City Hospital for patient satisfaction and outcomes in the neurology department. He serves as a faculty member at neurology continuing medical education events organized by Dubai Health Authority.